Naluri, a Malaysian digital health service provider has raised around $5 million from cornerstone investor Integra Partners of Singapore and the former investors Duopharma Biotech Berhad, Pathology Asia (via Biomark), and M Venture Partners. New investors include Hong Kong-based Sumitomo Corporation Equity Asia, Palm Drive Capital from New York, and Canadian firm INP Capital. The round was promoted by the Hibiscus Fund of Malaysia’s RHL Ventures and South Korea’s KB Investment.

Naluri would use its fresh funds to launch its service in Thailand and the Philippines and broaden its operations in Singapore and Indonesia. It also aims to build its technology and data science capabilities to improve its predictive algorithms. They include natural language processing and depression detection, device connectivity, and patient monitoring. The company is intending to use its upcoming funds to initiate clinical research in Europe. The health startup has partnered with large corporations in Southeast Asia, such as Reckitt, AXA Affin Berhad, Maxis, and SP Setia.

Naluri provides human-led and AI-augmented digital health coaching for chronic diseases such as renal disease, cancer, diabetes, hypertension, heart disease, and mental health conditions like anxiety and depression. It delivers multi-disciplinary support through structured programs and proprietary app-based tools for individuals and corporate clients.